PROM1 and colorectal carcinoma: We further separated the HCT116 CRC cell line into distinct CD133+ and CD133- populations, and combined this with a CD133-knockdown HCT116 cells xenograft model to investigate the potential regulatory relationship between CD133 and p85/p-AKT following SLNT treatment.